ATIIW Archimedes Tech SPAC Partners II Co. - Warrant
$2.41
Price · May 20, 2026
Fundamentals as of Mar 4, 2026
52W Range
$1–$2
97% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-123.3%
Net Profit Margin
—
ATIIW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.40
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
-123.3%
Debt/Equity
—
52W Range
$1 – $2
ATIIW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ATIIW
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ATIIW
Peer Median
ROA
6.6%
—
ROE
-123.3%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ATIIW
Peer Median
Current Ratio
10.7
—
Quick Ratio
9.9
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ATIIW
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ATIIW
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 6
| Metric | Trend | 2025 |
|---|---|---|
| SG&A Expense | $786.0K | |
| Operating Income | $-786.0K | |
| Interest Income | $9M | |
| Other Non-op | $9M | |
| Net Income | $8M | |
| EBITDA | $-786.0K |
Balance Sheet 13
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $1M | |
| Prepaid Expense | $111.4K | |
| Current Assets | $1M | |
| Total Assets | $241M | |
| Accrued Liabilities | $61.3K | |
| Current Liabilities | $137.5K | |
| Total Liabilities | $8M | |
| Common Stock | $659 | |
| Paid-in Capital | $0 | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $241M | |
| Shares Outstanding | 6,590,000 |
Cash Flow 4
| Metric | Trend | 2025 |
|---|---|---|
| Operating Cash Flow | $-739.0K | |
| Investing Cash Flow | $-231M | |
| Financing Cash Flow | $233M | |
| Net Change in Cash | $1M |
Profitability 2
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 6.6% | |
| ROE | -123.3% |
Liquidity & Solvency 2
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 10.7 | |
| Quick Ratio | 9.9 |
Valuation (TTM) 1
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $8M |
Income Statement 6
| Metric | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| SG&A Expense | $349.1K | $159.8K | $130.4K | $146.7K | |
| Operating Income | $-349.1K | $-159.8K | $-130.4K | $-146.7K | |
| Interest Income | $2M | $3M | $2M | $1M | |
| Other Non-op | $2M | $3M | $2M | $1M | |
| Net Income | $2M | $2M | $2M | $1M | |
| EBITDA | · | $-159.8K | $-130.4K | $-146.7K |
Balance Sheet 13
| Metric | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $1M | $2M | $2M | |
| Prepaid Expense | $111.4K | $338.8K | $134.4K | $157.5K | |
| Current Assets | $1M | $2M | $2M | $2M | |
| Total Assets | $241M | $239M | $237M | $235M | |
| Accrued Liabilities | $61.3K | $52.3K | $73.0K | $94.1K | |
| Current Liabilities | $137.5K | $128.6K | $159.1K | $172.1K | |
| Total Liabilities | $8M | $8M | $8M | $8M | |
| Common Stock | $659 | $659 | $659 | $659 | |
| Paid-in Capital | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-7M | $-6M | $-6M | $-6M | |
| Stockholders' Equity | $-7M | $-6M | $-6M | $-6M | |
| Liabilities + Equity | $241M | $239M | $237M | $235M | |
| Shares Outstanding | 6,590,000 | 6,590,000 | 6,590,000 | 6,590,000 |
Cash Flow 4
| Metric | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-45.1K | $-344.6K | $-95.4K | $-254.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $-231M | |
| Financing Cash Flow | $-1.3K | $-11.2K | $-2.9K | $233M | |
| Net Change in Cash | $-46.4K | $-355.7K | $-98.3K | $2M |
Profitability 2
| Metric | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| ROA | · | 2.0% | 2.0% | 0.99% | |
| ROE | · | -75.1% | -75.4% | -37.9% |
Liquidity & Solvency 2
| Metric | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | · | 13.6 | 11.9 | 11.7 | |
| Quick Ratio | · | 11.0 | 11.1 | 10.8 |
Valuation (TTM) 1
| Metric | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Net Income TTM | · | $6M | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Net Income | $8M | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Debt / Equity | — | -3.6 |
| Current Ratio | 10.7 | — |
| Quick Ratio | 9.9 | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.